Kliniska studier för Lymfom i Maryland
21 studier för Lymfom söker deltagare vid platser i Maryland.
Städer i Maryland
Officiell studietext (engelska)
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 2
Ålder 12 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT03258567Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 3 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT01441089CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1/2
Ålder 3 till 39 · Alla kön · Uppdaterad 30 sep. 2026 · NCT05442515Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 28 sep. 2026 · NCT00006518Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 18 till 110 · Alla kön · Uppdaterad 28 sep. 2026 · NCT00923507Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1/2
Ålder 18 till 120 · Alla kön · Uppdaterad 28 sep. 2026 · NCT03223610Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekryterarTidig fas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT06398457A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
- Maryland Oncology Hematology, Silver Spring
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT07221500Collection of Tissue Samples for Cancer Research
- Johns Hopkins University, Baltimore
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
2 Months · Alla kön · Uppdaterad 16 sep. 2026 · NCT00900198CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekryterarFas 1/2
12 Months – 21 Years · Alla kön · Uppdaterad 11 sep. 2026 · NCT04870944Sample Collection and Tracking for the Developmental Therapeutics Clinic
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudie
Ålder 18 till 120 · Alla kön · Uppdaterad 8 sep. 2026 · NCT03269578Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
- Research Site, Bethesda
RekryterarFas 3
Ålder 18 till 18 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07509151Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
- Walter Reed National Military Medical Center, Bethesda
RekryterarObservationsstudie
Ålder 4 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07652580Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 5 och äldre · Alla kön · Uppdaterad 31 aug. 2026 · NCT05237986Vaccine Responses in Patients With B Cell Malignancies
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 4
Ålder 18 till 90 · Alla kön · Uppdaterad 4 aug. 2026 · NCT05170399DALY II USA/ MB-CART2019.1 for DLBCL
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT04792489A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- National Institute of Health, Bethesda
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 juli 2026 · NCT05131022Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 1 juni 2026 · NCT05663502Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
- National Institutes of Health Clinical Center, Bethesda
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 120 · Alla kön · Uppdaterad 27 maj 2026 · NCT06856226Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 18 maj 2026 · NCT01790152A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
- National Institutes of Health Clinical Center, Bethesda
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 20 mars 2026 · NCT04830137Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.